Oryzon Genomics (Spain) Price History
ORY Stock | EUR 1.56 0.02 1.27% |
If you're considering investing in Oryzon Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oryzon Genomics stands at 1.56, as last reported on the 12th of December 2024, with the highest price reaching 1.59 and the lowest price hitting 1.55 during the day. Oryzon Genomics SA maintains Sharpe Ratio (i.e., Efficiency) of -0.2, which implies the firm had a -0.2% return per unit of risk over the last 3 months. Oryzon Genomics SA exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oryzon Genomics' Coefficient Of Variation of (477.12), risk adjusted performance of (0.15), and Variance of 2.0 to confirm the risk estimate we provide.
Oryzon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Oryzon |
Sharpe Ratio = -0.2019
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ORY |
Estimated Market Risk
1.43 actual daily | 12 88% of assets are more volatile |
Expected Return
-0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oryzon Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oryzon Genomics by adding Oryzon Genomics to a well-diversified portfolio.
Oryzon Genomics Stock Price History Chart
There are several ways to analyze Oryzon Stock price data. The simplest method is using a basic Oryzon candlestick price chart, which shows Oryzon Genomics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 25, 2024 | 1.88 |
Lowest Price | November 26, 2024 | 1.51 |
Oryzon Genomics December 12, 2024 Stock Price Synopsis
Various analyses of Oryzon Genomics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Oryzon Stock. It can be used to describe the percentage change in the price of Oryzon Genomics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Oryzon Stock.Oryzon Genomics Price Rate Of Daily Change | 0.99 | |
Oryzon Genomics Price Daily Balance Of Power | (0.50) | |
Oryzon Genomics Accumulation Distribution | 863.62 | |
Oryzon Genomics Price Action Indicator | (0.02) |
Oryzon Genomics December 12, 2024 Stock Price Analysis
Oryzon Stock Price History Data
The price series of Oryzon Genomics for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 has a statistical range of 0.4 with a coefficient of variation of 7.26. The daily prices for the period are spread out with arithmetic mean of 1.71. The median price for the last 90 days is 1.7.Open | High | Low | Close | Volume | ||
12/11/2024 | 1.58 | 1.59 | 1.55 | 1.56 | 34,329 | |
12/10/2024 | 1.56 | 1.58 | 1.54 | 1.58 | 73,799 | |
12/09/2024 | 1.54 | 1.56 | 1.54 | 1.54 | 77,070 | |
12/06/2024 | 1.53 | 1.56 | 1.52 | 1.55 | 96,867 | |
12/05/2024 | 1.51 | 1.53 | 1.51 | 1.53 | 103,830 | |
12/04/2024 | 1.54 | 1.54 | 1.51 | 1.53 | 52,294 | |
12/03/2024 | 1.55 | 1.56 | 1.52 | 1.53 | 146,559 | |
12/02/2024 | 1.54 | 1.57 | 1.52 | 1.55 | 67,855 | |
11/29/2024 | 1.59 | 1.60 | 1.54 | 1.54 | 104,131 | |
11/28/2024 | 1.51 | 1.58 | 1.50 | 1.57 | 131,020 | |
11/27/2024 | 1.52 | 1.52 | 1.49 | 1.51 | 135,704 | |
11/26/2024 | 1.53 | 1.55 | 1.49 | 1.51 | 306,759 | |
11/25/2024 | 1.54 | 1.55 | 1.54 | 1.54 | 138,598 | |
11/22/2024 | 1.58 | 1.58 | 1.53 | 1.56 | 112,589 | |
11/21/2024 | 1.58 | 1.60 | 1.55 | 1.57 | 119,657 | |
11/20/2024 | 1.61 | 1.61 | 1.58 | 1.58 | 176,180 | |
11/19/2024 | 1.62 | 1.63 | 1.59 | 1.59 | 122,115 | |
11/18/2024 | 1.60 | 1.65 | 1.60 | 1.62 | 216,902 | |
11/15/2024 | 1.64 | 1.66 | 1.63 | 1.66 | 31,087 | |
11/14/2024 | 1.67 | 1.67 | 1.62 | 1.67 | 99,057 | |
11/13/2024 | 1.66 | 1.67 | 1.63 | 1.64 | 94,090 | |
11/12/2024 | 1.72 | 1.72 | 1.62 | 1.63 | 132,233 | |
11/11/2024 | 1.65 | 1.71 | 1.65 | 1.70 | 161,672 | |
11/08/2024 | 1.62 | 1.62 | 1.58 | 1.62 | 91,930 | |
11/07/2024 | 1.63 | 1.63 | 1.60 | 1.60 | 128,214 | |
11/06/2024 | 1.63 | 1.63 | 1.60 | 1.62 | 72,101 | |
11/05/2024 | 1.63 | 1.64 | 1.60 | 1.62 | 134,136 | |
11/04/2024 | 1.64 | 1.69 | 1.63 | 1.63 | 79,635 | |
11/01/2024 | 1.65 | 1.65 | 1.63 | 1.64 | 69,354 | |
10/31/2024 | 1.65 | 1.70 | 1.63 | 1.65 | 121,049 | |
10/30/2024 | 1.71 | 1.71 | 1.67 | 1.67 | 86,258 | |
10/29/2024 | 1.69 | 1.71 | 1.68 | 1.68 | 52,794 | |
10/28/2024 | 1.70 | 1.70 | 1.68 | 1.68 | 87,165 | |
10/25/2024 | 1.74 | 1.74 | 1.69 | 1.70 | 187,148 | |
10/24/2024 | 1.73 | 1.75 | 1.73 | 1.74 | 80,110 | |
10/23/2024 | 1.74 | 1.76 | 1.74 | 1.74 | 15,485 | |
10/22/2024 | 1.77 | 1.77 | 1.73 | 1.74 | 93,884 | |
10/21/2024 | 1.79 | 1.79 | 1.76 | 1.77 | 57,553 | |
10/18/2024 | 1.80 | 1.82 | 1.79 | 1.79 | 39,843 | |
10/17/2024 | 1.80 | 1.80 | 1.79 | 1.79 | 51,345 | |
10/16/2024 | 1.79 | 1.80 | 1.77 | 1.80 | 107,834 | |
10/15/2024 | 1.79 | 1.80 | 1.77 | 1.78 | 70,707 | |
10/14/2024 | 1.76 | 1.79 | 1.76 | 1.77 | 75,113 | |
10/11/2024 | 1.77 | 1.81 | 1.75 | 1.76 | 104,884 | |
10/10/2024 | 1.79 | 1.80 | 1.78 | 1.78 | 44,574 | |
10/09/2024 | 1.80 | 1.81 | 1.78 | 1.79 | 54,471 | |
10/08/2024 | 1.81 | 1.83 | 1.80 | 1.80 | 58,997 | |
10/07/2024 | 1.83 | 1.83 | 1.80 | 1.80 | 111,076 | |
10/04/2024 | 1.81 | 1.84 | 1.81 | 1.82 | 51,871 | |
10/03/2024 | 1.82 | 1.84 | 1.81 | 1.82 | 58,276 | |
10/02/2024 | 1.82 | 1.84 | 1.79 | 1.80 | 128,125 | |
10/01/2024 | 1.85 | 1.88 | 1.79 | 1.81 | 368,039 | |
09/30/2024 | 1.85 | 1.87 | 1.81 | 1.81 | 139,342 | |
09/27/2024 | 1.85 | 1.88 | 1.85 | 1.85 | 66,014 | |
09/26/2024 | 1.88 | 1.91 | 1.85 | 1.85 | 80,649 | |
09/25/2024 | 1.88 | 1.88 | 1.86 | 1.88 | 48,102 | |
09/24/2024 | 1.86 | 1.90 | 1.85 | 1.86 | 194,456 | |
09/23/2024 | 1.90 | 1.97 | 1.86 | 1.87 | 393,266 | |
09/20/2024 | 1.90 | 1.94 | 1.84 | 1.84 | 456,104 | |
09/19/2024 | 1.86 | 1.89 | 1.86 | 1.87 | 48,069 | |
09/18/2024 | 1.89 | 1.90 | 1.87 | 1.87 | 48,412 |
About Oryzon Genomics Stock history
Oryzon Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oryzon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oryzon Genomics SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oryzon Genomics stock prices may prove useful in developing a viable investing in Oryzon Genomics
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases. Oryzon Genomics S.A. was founded in 2000 and is based in Barcelona, Spain. ORYZON GENOMICS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 40 people.
Oryzon Genomics Stock Technical Analysis
Oryzon Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
All Next | Launch Module |
Oryzon Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oryzon Genomics' price direction in advance. Along with the technical and fundamental analysis of Oryzon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oryzon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.15) | |||
Jensen Alpha | (0.29) | |||
Total Risk Alpha | (0.53) | |||
Treynor Ratio | 1.78 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Oryzon Stock analysis
When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |